NCT03510611 - A Study to Investigate the Food Effect on the Pharmacokinetics of Ensartinib Capsules in Chinese Healthy Volunteers. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

August 2, 2018

Study Completion Date

August 2, 2018

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

Ensartinib with fed or fasting

The two groups of subjects were given an equal dose of Ensartinib capsules (225 mg) after a single cross-over fasting or high-fat high-calorie diet in two different test cycles to examine the effect of food on the pharmacokinetics of Ensartinib.

Trial Locations (1)

311009

The 1st Phase Clinical Research Center of the Second Affiliated Hospital of Zhejiang University Medical College, Hangzhou